Anthony A. DiTonno Net Worth

Mr. Anthony A. DiTonno biography

Anthony A. DiTonno is the CEO & Director at Tenax Therapeutics Inc.

What is the salary of Mr DiTonno?

As the CEO & Director of Tenax Therapeutics Inc, the total compensation of Mr DiTonno at Tenax Therapeutics Inc is $505,250. There are 1 executives at Tenax Therapeutics Inc getting paid more, with Michael B. Jebsen CPA having the highest compensation of $525,825.

How old is Mr DiTonno?

Mr DiTonno is 72, he's been the CEO & Director of Tenax Therapeutics Inc since . There are 1 older and 14 younger executives at Tenax Therapeutics Inc. The oldest executive at Tenax Therapeutics Inc is Ronald Blanck, 75, who is the Independent Chairman of the Board.

What's Mr DiTonno's mailing address?

Anthony's mailing address filed with the SEC is C/O TENAX THERAPEUTICS, INC., ONE COPLEY PARKWAY, SUITE 490, MORRISVILLE, NC, 27560.

Insiders trading at Tenax Therapeutics Inc

Over the last 10 years, insiders at Tenax Therapeutics Inc have traded over $5,051 worth of Tenax Therapeutics Inc stock and bought 571,282 units worth $853,236 . The most active insiders traders include Capital, Llc Armistice Capi..., Declan Doogan és Stuart Rich. On average, Tenax Therapeutics Inc executives and independent directors trade stock every 218 days with the average trade being worth of $1,664,103. The most recent stock trade was executed by Gerald T Proehl on 8 August 2024, trading 1,666 units of TENX stock currently worth $6,131.

What does Tenax Therapeutics Inc do?

tenax therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.

Tenax Therapeutics Inc executives and stock owners

Tenax Therapeutics Inc executives and other stock owners filed with the SEC include:

• Michael B. Jebsen CPA,
  Advisor
• Anthony A. DiTonno,
  CEO & Director
• Michael Jebsen,
  President, Chief Financial Officer
• Michael B. Jebsen,
  Pres & CFO
• Christopher T. Giordano,
  CEO, Pres & Director
• Ellen Corliss,
  Vice President, Corporate Communications & Investor Relations
• Chris Rallis,
  Independent Director
• Gregory Pepin,
  Independent Director
• Gerald Proehl,
  Director
• James Mitchum,
  Director
• Keith Maher,
  Director
• Steven Boyd,
  Director
• Paula Bokesch,
  Chief Medical Officer
• Doug Randall,
  Executive Vice President - Business and Commercial Operations
• Douglas Hay,
  Executive Vice President - Regulatory Affairs
• Anthony DiTonno,
  Chief Executive Officer, Director
• Ronald Blanck,
  Independent Chairman of the Board
• Eliot M. Lurier CPA,
  Interim Chief Financial Officer
• Dr. Stuart Rich M.D.,
  Chairman of Scientific Advisory Board, Chief Medical Officer & Director
• Nancy J. M. Hecox,
  Exec. VP of Legal Affairs, Gen. Counsel & Corp. Sec.
• John P Kelley,
  Chief Executive Officer
• Michael H. Davidson,
  
• Declan Doogan,
  
• Stuart Rich,
  Chief Medical Officer
• June Sherie Almenoff,
  
• Robyn Hunter,
  
• Christopher Thomas Giordano,
  CEO